EGFR Kinase Inhibitor 4 (Compound 4) acts as a bivalent ATP-allosteric inhibitor targeting EGFR, with a potent inhibitory effect (IC 50: 1.8 nM) on mutant EGFR (LRTMCS). It is primarily utilized in the study of non-small cell lung cancer (NSCLC) [1].
Molecular Weight:
690.75
CAS Number:
[2922402-05-7]
Formula:
C40H34N8O4
Target:
EGFR
T86342
* VAT and and shipping costs not included. Errors and price changes excepted
